Melanoma: What are your tips about immunotherapy (Keytruda)?

Posted by williamfh @williamfh, Dec 29, 2024

It started a year ago, nodular melanoma on my right arm. Had incision to remove. Stated they got it all. Checked two lymph nodes. One negative, 1 small traces of cancer cells. A year later, two pumps come up very near the same spot. Its cancer again. Doctor wants to try Keytruda, Neoadjuvant immunotherapy. Starting the drug before the tumor is taken out. I'm concerned the tumor will grow in 6 weeks and may spread while getting treatment, which could make things worse. She states I'm a good candidate because of my positive TPS 6-10% and my TMB 52.6. After reading up on this drug I'm very nervous about the side effects, many that are permanent and non reversible. Latest stage diagnose is melanoma stage 3C because it recurred. I'm kinda at a loss with direction to go. Any experience using this drug out there?

Interested in more discussions like this? Go to the Melanoma & Skin Cancer Support Group.

Aside from living in Florida, I don't know much about melanoma, and have zero medical training. I'm a pancreatic cancer patient who wound up in this thread by a random link. 🙂

With that said, in pancreatic cancer, the standard surgery (Whipple procedure) is very invasive and debilitating for several weeks/months; the average patient requires that much time for recovery before any adjuvant chemo or immunotherapy can start. They sometimes use neoadjuvant chemo to reduce tumor incursion into major arteries before surgery, and sometimes use it just to provide systemic therapy to prevent/kill potential metastases before surgery.

With melanoma on the arm, surgical removal doesn't seem like it should delay the immediate startup of immunotherapy. My inclination would be to undertake both immediately to prevent the spread and start the (potential) cure.

With pancreatic cancer (and many others; not sure about melanoma), the resected malignant tissue can be sequenced in various ways to identify mutations and also to create a tumor-specific ctDNA test like Signatera.

Signatera is a repeat blood test that counts the number of ctDNA cells matching your original tumor per mL of blood. It can be used as a metric to determine a treatment's effectiveness (e.g., it gives a quantitative result that you hope will go downward from non-zero to zero over the course of treatment).

It takes a couple weeks from tissue acquisition to create the Signatera test; the sooner they acquire and submit tissue the sooner they can start using it. It sounds like they already have tissue they could submit based on what they removed last year.

You would miss a few blood test opportunities if you started immunotherapy before the initial Signatera test is ready. The sooner you get it created, the sooner you can start using it. Again, I'm not sure if this is applicable for melanoma.

But the sooner you get surgery and immunotherapy, the sooner you start attacking the cancer from both sides. I would ask if there is any benefit to delaying the surgery vs. having surgery AND starting immunotherapy immediately.

Wishing you the best. Hope you can share your oncologist's responses regarding the above.

REPLY
Please sign in or register to post a reply.